New Emergence client, Because Animals, started by two Torontonians, is a company making human grade sustainable, animal-free pet food. Shannon Falconer has a PhD in microbial chemical biology and worked as a postdoctoral fellow at Stanford University. Joshua has worked as a journalist, banker and cat rescuer. He graduated with an MBA from Indiana University’s Kelley School of Business. Because Animals already has a couple of superfood supplements for both dogs and cats, and now they are developing lab-grown meat for pet food. They recently announced a prototype cat treat. They are one of the companies that sees opportunities.  Read more here.

On April 23, 2019, all shares in leading aquaculture R&D company The Center for Aquaculture Technologies (CAT), were purchased by Cuna Del Mar LP (CDM), a US-based aquaculture investment fund, for an undisclosed amount from Linnaeus Capital Partners BV.

Dr. John Buchanan, CEO of CAT, commented: “We look forward to working within Cuna del Mar, a fund that clearly sees the potential for growth in the aquaculture industry.”

Robert Orr, Managing Director of Cuna Del Mar, added “Cuna del Mar is very pleased to be acquiring the CAT operations in the USA and Canada. CAT has a tremendously talented team of people with unique capabilities, who are dedicated to making a difference for our customers and the industry as a whole. We are excited about the possibilities the future holds for this business.”

CAT currently operates two laboratories: its research hub in San Diego, California, and state-of-the-art wet lab facilities including BSL 3 containment for aquatic animal pathogens, located on Prince Edward Island in Canada. Thanks to the expertise of its team and the unique versatility of its laboratories, CAT is enabling the aquaculture industry to achieve efficient production of through genetic improvement as well as facilitating commercial development of innovative feed and health management products and services.

With Cuna Del Mar, CAT looks forward to working with other companies within the CDM portfolio and to expanding its capacity for conduct of aquaculture contract research and services in support of the global aquaculture industry.

For more information, please contact Debbie Plouffe at dplouffe@aquatechcenter.com or at 902-687-1245.

CAT is a member of the Emergence Bio-incubator.

RPS Biologiques Inc. is pleased to announce the reception of two (2) Notification Numbers from the Health Canada Veterinary Drugs Directorate (VDD) for their Veterinary Health Products (VHP), Supratect-L and Supratect -P. The Notification Numbers indicate approval, allowing for marketing and sale of Supratect in Canada. The use of Supratect has been fully tested for the maintenance of optimal health of fish and fish eggs in finfish species. It consists of natural ingredients that are completely safe and beneficial for the target species. Supratect is the first and only current Natural fish health product to receive approval, in Canada, through the Veterinary Health Products notification program.

The President of RPS Biologiques, Dr. Subrata Chowdhury, says the objective of the company is to become a leader in developing safe, all natural, fish health products for use in the aquaculture sector. Dr. Chowdhury is a molecular biologist with wide experience in the fields of microbiology, virology, immunology and genetics. He notes that RPS Biologiques is continuing to develop additional, unique natural products for use in the animal health sector.

The testing undertaken to validate Supratect was completed, over a three-year period, mainly at the Huntsman Marine Science Centre located in St Andrews, New Brunswick. Established in 1969, Huntsman is a private, not-for-profit research and science based teaching institution whose work is recognized throughout Canada and internationally.

Paul Dick & Associates (PDA), a global consulting company, worked with RPS Biologiques and Health Canada to obtain notification for Supratect via the VHP program. The firm specializes in the development and registration of animal and human health products including veterinary biologics, veterinary drugs, feeds and natural health products.

RPS Biologiques Inc is a privately-owned Canadian company based in Charlottetown, Prince Edward Island and a member of the PEI Bioalliance Emergence Bio-incubator.

Emergence client Dosecann, a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets, is currently hiring for 12 new positions. Positions include:

• HR Manager
• Analytical Scientist I
• Warehouse Clerk
• HR Manager
• Analytical Scientist II
• Analytical Scientist III
• QC Chemist
• Extraction Technician
• Formulation Scientist
• Packaging Technician
• QA Specialist
• QA Support – Validation/Documentation

See more details on these positions here.

Dosecann has assembled a world-class team housed in a purpose-built, 42,000 sqft. GMP compliant facility that will be the hub for cannabis extraction, product innovation and formulation.

Emergence clients Ethicann Pharmaceuticals, a company that sources pharmaceutical-grade botanically sourced cannaboid oils to formulate ethical drugs has closed a successful initial financing round. Several Canadian and US venture funds and high net worth individuals and entrepreneurs with considerable industry experience are the investors.

One of Ethicann’s recent milestones saw their US subsidiary holding successful Pre-IND meeting with the US Food and Drug Administration to discuss the 505(b)2 requirements for a marketing approval for its first product (CAN-001) to treat chemotherapy-induced nausea and vomiting.

For more details on the company and their latest achievement, click here..

Avivagen has been analyzing opportunities to combine their propietary product OxC-betaTM with licensed cannabis products and they believe there are various combinations that could result in new products for the company. For the full news release, click here.

“We are enthusiastic about working with leading edge cannabis companies and participating in their development of a line of products which incorporate our unique OxC-beta™ technology,” says Kym Anthony, Chairman and Interim CEO, Avivagen. “We have been vocal advocates for the benefits of new product categories and look forward to collaborating with these large, well-resourced and innovative companies to bring these innovative products to the worldwide market, where appropriate.”

About Avivagen
Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance.  It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit www.avivagen.com.

Emergence client SomaDetect will join other innovators to be part of the 2019 Pearse Lyons Accelerator. In its third year, this Accelerator received 250 applications worldwide and SomaDetect was among only 10 startups chosen. Together they offer a glimpse of what the future of farming will be. See the full list here. These startups will gain access to expertise, funding, networking, presentation and mentorship opportunities that will boost their global success.

This good news adds to their growing list of achievements that include receiving $1M US as the top startup in the Buffalo-based 43North accelerator’s 2017 cohort and, in 2018, investment from the Dairy Farmers of America which represents almost 15,000 farmers. For a full list of achievement, read their news here.

Read more about the Pearse Lyons Accelerator here.

Emergence welcomes its latest client Active AgriScience to Canada’s bioscience incubator program!

Active AgriScience is an award-winning leading global manufacturer of innovative foliar nutrition products developed to solve grower’s problems and to increase production yields.

Their ground-breaking research conducted by network of laboratories combined with independent third-party verification of efficacy allows growers to improve production, quality, and profits while reducing the impact on the environment.

Headquartered in Abbotsford, BC with manufacturing facilities in Canada and the USA, Active AgriScience exports its products to Asia, Australia, Europe, and across North America. The company’s patented bioactive molecule Intrinsic® offers numerous benefits through each stage of the plant growth cycle. Offering a complete nutritional system for Field Crops, Hydroponic and Organic growers, our key products include Active Prime™, Active Build™, Active Flower™, Active Complete™, Active InFurrow™, and Active Konnect™. More product details here.

Active AgriScience has also developed dual action nitrogen management technology in the form of ARM U™ and ARM U™ ADVANCED. These fertilizer additives when treated to urea drastically enhance plant’s ability to absorb and utilize up to 95% of the available nitrogen, which otherwise, if untreated, volatilizes by as much as 50% through conversion of nitrogen to ammonia gas or leaches into the ground water through nitrification.

Watch their video to learn more:

Meet their team.